Tectonic Therapeutic (TECX) Accumulated Depreciation (2017 - 2025)
Tectonic Therapeutic (TECX) posted quarterly Accumulated Depreciation of $3.4 million for Q4 2025, up 24.12% year-over-year from $2.7 million in Q4 2024, and up 7.14% quarter-over-quarter from $3.2 million in Q3 2025.
Analysis
Tectonic Therapeutic (TECX) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Accumulated Depreciation for 9 consecutive years, with $3.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 24.12% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (up 24.12% YoY), while the FY2025 annual figure was $3.4 million, up 24.12% from the prior year.
- Accumulated Depreciation advanced to $3.4 million in Q4 2025 per TECX's latest filing, from $3.2 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $4.6 million in Q2 2022 and bottomed at $1.9 million in Q4 2023.
- Historically, Accumulated Depreciation has averaged $3.4 million across 5 years, with a median of $3.4 million in 2021.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation soared 78.77% — and 2023, when it tumbled 51.21%.
- Tectonic Therapeutic's Accumulated Depreciation stood at $3.8 million in 2021, then declined by 0.42% to $3.8 million in 2022, then slumped by 51.21% to $1.9 million in 2023, then soared by 47.9% to $2.7 million in 2024, then increased by 24.12% to $3.4 million in 2025.
- Business Quant data shows TECX's Accumulated Depreciation at $3.4 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 3.01 Mn |
| Mar 31, 2021 | 2.71 Mn |
| Dec 31, 2020 | 2.42 Mn |
| Sep 30, 2020 | 2.13 Mn |